Building Evidence to Expand Adolescent Vaccination in Pharmacies

University of North Carolina, Chapel Hill2 sites in 1 country1,509 target enrollmentJuly 2015

ConditionsEvaluating Attitudes Toward HPV Vaccinations in Pharmacies Evaluating the Provision of HPV Vaccines in a Pharmacy

InterventionsHPV vaccine

Overview

Phase: N/A
Intervention: HPV vaccine
Conditions: Evaluating Attitudes Toward HPV Vaccinations in Pharmacies
Sponsor: University of North Carolina, Chapel Hill
Enrollment: 1509
Locations: 2
Primary Endpoint: Parents' willingness to get their adolescent children HPV vaccine in pharmacy
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the second part of the study, we will provide HPV vaccines and other vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems and workflow needed to provide vaccines effectively and safely, characterize parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy, and characterize pharmacists' attitudes toward providing adolescent vaccine services in a pharmacy.

Registry

clinicaltrials.gov

Start Date

July 2015

End Date

April 2018

Last Updated

8 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of North Carolina, Chapel Hill

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Being a member of the GfK Knowledge Panel
•Having a child age 11-18.

Exclusion Criteria

•PHARMACY DEMONSTRATION PROJECT (convenience sample)
•Inclusion Criteria:
•Having an adolescent child, ages 11-18 years old, who is healthy, and for whom HPV vaccine is indicated
•Child is with the parent
•Exclusion Criteria:
•● Being the parent of an adolescent who is immunocompromised, or has other chronic illness, has known anaphylactoid/hypersensitivity reactions to components of HPV vaccine used, or is pregnant or plan to be pregnant within a month of vaccination.